Mechanism of action Colorized scanning electron micrograph of Ebola virus particles (green)<unk>  is a combination of Zaire ebolavirus glycoprotein-directed human monoclonal antibodies. The three antibodies target the glycoprotein that is on the surface of the Ebola virus. This glycoprotein normally attaches to the cell via a receptor and fuses the viral and host cell membranes allowing the virus to enter the cell. The antibodies can bind to it simultaneously at three different locations and block attachment and entry of the virus. This combination drug targets the Zaire species of Ebola virus. The Sudan and Bundibugyo strains have also caused outbreaks, and it is unlikely that it would be effective against these strains.
Atoltivimab/maftivimab/odesivimab
Casirivimab/imdevimab
Bamlanivimab/etesevimab
Tixagevimab/cilgavimab
Valoctocogene roxaparvovec
Baloxavir marboxil
Darunavir/cobicistat
Belantamab mafodotin